Skip to main content
Fig. 3 | Biology of Sex Differences

Fig. 3

From: Role of GDF-15, YKL-40 and MMP 9 in patients with end-stage kidney disease: focus on sex-specific associations with vascular outcomes and all-cause mortality

Fig. 3

Average GDF-15 concentration in regards of CVD severity in males and females. CVD severity assessed by CT scan and extent of coronary artery calcification set to a nominal scale ranging from none (Agatston score = 0; females n = 17; males n = 23), mild to moderate (Agatston score = 1–400; females n = 13; males n = 23), and severe calcification (Agatston score > 400; females n = 12; males n = 29). Data presented as median (IQR). Kruskal–Wallis; **p < 0.01

Back to article page